ABELCET

This brand name is authorized in Brazil, Canada, Spain, France, Croatia, Mexico, Netherlands, Poland, Turkey, United Kingdom, United States

Active ingredients

The drug ABELCET contains one active pharmaceutical ingredient (API):

1 Amphotericin B UNII 7XU7A7DROE - AMPHOTERICIN B

Amphotericin B is a macrocyclic, polyene antifungal antibiotic produced by Streptomyces nodosus. The molecule is thought to act by binding to sterols in the fungal cell membrane, with a resulting change in membrane permeability, allowing leakage of a variety of small molecules. Read about Amphotericin B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J02AA01	Amphotericin B	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AA Antibiotics
Discover more medicines within J02AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525500605111312
Country: CA	Health Products and Food Branch	Identifier(s): 02231590
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60945
Country: FR	Base de données publique des médicaments	Identifier(s): 66207341
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 213026, 79837
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 218M2000
Country: NL	Z-Index G-Standaard	Identifier(s): 15016757
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 38849
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100111765
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699783690168
Country: US	FDA, National Drug Code	Identifier(s): 57665-101